NYSEAMERICAN:NSPR - InspireMD Stock Price, Price Target & More

$1.30 +0.04 (+3.17 %)
(As of 04/19/2018 11:31 AM ET)
Previous Close$1.26
Today's Range$1.21 - $1.38
52-Week Range$0.70 - $28.70
Volume417,236 shs
Average Volume676,143 shs
Market Capitalization$7.11 million
P/E RatioN/A
Dividend YieldN/A
Beta2.61

About InspireMD (NYSEAMERICAN:NSPR)

InspireMD logoInspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular diseases. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. It is also developing NGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms in order to seal the aneurysms. InspireMD, Inc. distributes its products in Europe, Latin America, the Middle East, and Asia. The company is headquartered in Tel Aviv, Israel.

Receive NSPR News and Ratings via Email

Sign-up to receive the latest news and ratings for NSPR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Appliances & Equipment
Sub-IndustryN/A
SectorMedical
SymbolNYSEAMERICAN:NSPR
CUSIPN/A
Phone+1-857-4536553

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-179.74%
Return on Equity-720.33%
Return on Assets-90.96%

Miscellaneous

EmployeesN/A
Outstanding Shares3,000,000

How to Become a New Pot Stock Millionaire

InspireMD (NYSEAMERICAN:NSPR) Frequently Asked Questions

What is InspireMD's stock symbol?

InspireMD trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "NSPR."

When did InspireMD's stock split? How did InspireMD's stock split work?

InspireMD's stock reverse split on Thursday, February 8th 2018. The 1-35 reverse split was announced on Wednesday, February 7th 2018. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, February 7th 2018. An investor that had 100 shares of InspireMD stock prior to the reverse split would have 3 shares after the split.

How were InspireMD's earnings last quarter?

InspireMD (NYSEAMERICAN:NSPR) announced its quarterly earnings data on Wednesday, February, 14th. The medical equipment provider reported ($7.38) EPS for the quarter. The medical equipment provider had revenue of $0.83 million for the quarter. InspireMD had a negative return on equity of 720.33% and a negative net margin of 179.74%. View InspireMD's Earnings History.

Are investors shorting InspireMD?

InspireMD saw a increase in short interest in March. As of March 29th, there was short interest totalling 291,391 shares, an increase of 66.4% from the March 15th total of 175,161 shares. Based on an average trading volume of 1,535,386 shares, the days-to-cover ratio is presently 0.2 days. Currently, 5.1% of the shares of the stock are short sold.

Who are some of InspireMD's key competitors?

Who are InspireMD's key executives?

InspireMD's management team includes the folowing people:
  • Dr. James J. Barry Ph.D., Pres, CEO & Director (Age 59)
  • Mr. Craig Shore, CFO, Chief Admin. Officer, Treasurer & Sec. (Age 57)
  • Mr. Agustin V. Gago, Exec. VP & Chief Commercial Officer (Age 58)
  • Dr. Sol J. Barer, Special Advisor to the Board (Age 71)
  • Mr. Benzi Spector, Head of R&D and Operations

Has InspireMD been receiving favorable news coverage?

Media coverage about NSPR stock has been trending somewhat positive recently, according to Accern. Accern scores the sentiment of media coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. InspireMD earned a coverage optimism score of 0.06 on Accern's scale. They also assigned media coverage about the medical equipment provider an impact score of 45.89 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near term.

How do I buy shares of InspireMD?

Shares of NSPR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is InspireMD's stock price today?

One share of NSPR stock can currently be purchased for approximately $1.34.

How big of a company is InspireMD?

InspireMD has a market capitalization of $7.11 million.

How can I contact InspireMD?

InspireMD's mailing address is 4 Menorat Hamaor St., TEL AVIV-YAFO, MA 6744832, Israel. The medical equipment provider can be reached via phone at +1-857-4536553.


MarketBeat Community Rating for InspireMD (NSPR)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  88 (Vote Outperform)
Underperform Votes:  84 (Vote Underperform)
Total Votes:  172
MarketBeat's community ratings are surveys of what our community members think about InspireMD and other stocks. Vote "Outperform" if you believe NSPR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NSPR will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

InspireMD (NYSEAMERICAN:NSPR) Analyst Ratings History

DateBrokerageActionRatingPrice TargetDetails
(Data available from 4/19/2016 forward)

Earnings

InspireMD (NYSEAMERICAN:NSPR) Earnings History and Estimates Chart

Earnings by Quarter for InspireMD (NYSEAMERICAN:NSPR)

InspireMD (NYSEAMERICAN NSPR) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/14/2018Q4 2017($7.38)$0.83 millionViewN/AView Earnings Details
11/7/2017Q3 2017($6.65)$0.72 millionViewN/AView Earnings Details
8/8/2017Q2 2017($7.35)$0.64 millionViewN/AView Earnings Details
5/9/2017Q1 2017($28.35)$0.57 millionViewN/AView Earnings Details
2/16/2017Q4 2016($30.80)$0.32 millionViewN/AView Earnings Details
11/14/2016Q3 2016($30.10)$0.47 millionViewN/AView Earnings Details
8/9/2016Q216($5.95)($6.65)$0.80 million$0.54 millionViewN/AView Earnings Details
5/10/2016Q1 2016($306.25)($280.00)$0.70 million$0.56 millionViewN/AView Earnings Details
3/28/2016Q415($16.10)($12.95)$0.80 million$0.52 millionViewN/AView Earnings Details
11/10/2015Q315($17.50)($15.75)$0.63 millionViewListenView Earnings Details
8/5/2015Q215($1.75)($1.75)$0.69 millionViewN/AView Earnings Details
5/11/2015Q214($1.75)($2.80)$0.90 million$0.48 millionViewListenView Earnings Details
3/12/2015Q4 2014($5.95)($4.20)$0.07 million$0.87 millionViewN/AView Earnings Details
11/12/2014Q3 2014($1,925.00)($1,750.00)$0.40 million$0.27 millionViewN/AView Earnings Details
7/23/2014Q2 2014($1,925.00)$1.75 million$0.19 millionViewN/AView Earnings Details
5/7/2014Q1 2014($5.25)($6.30)$1.65 million$1.48 millionViewN/AView Earnings Details
2/26/2014Q4 2013($1,400.00)$1.90 million$1.55 millionViewN/AView Earnings Details
11/11/2013Q114($3.85)($3.15)$1.60 million$2.30 millionViewN/AView Earnings Details
9/17/2013Q413($4.55)($3.50)$1.50 million$1.50 millionViewN/AView Earnings Details
5/8/2013Q313($9.45)$1.14 million$1.51 millionViewN/AView Earnings Details
2/4/2013Q4 2012$962.50ViewN/AView Earnings Details
11/2/2012Q3 2012($3,850.00)ViewN/AView Earnings Details
9/12/2012Q2 2012($1,750.00)ViewN/AView Earnings Details
5/8/2012Q1 2012($1,750.00)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

InspireMD (NYSEAMERICAN:NSPR) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

InspireMD (NYSEAMERICAN NSPR) Insider Trading and Institutional Ownership History

Insider Trading History for InspireMD (NYSEAMERICAN:NSPR)

InspireMD (NYSEAMERICAN NSPR) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/21/2016Paul StukaDirectorBuy127,119$0.59$75,000.21View SEC Filing  
5/29/2014Eric L OlsonVPBuy31,778$2.55$81,033.90View SEC Filing  
5/13/2014Sol J BarerDirectorBuy50,000$2.44$122,000.00View SEC Filing  
5/12/2014Alan MilinazzoCEOBuy7,100$2.36$16,756.00View SEC Filing  
11/26/2013Asher HolzerDirectorSell597,300$2.64$1,576,872.00View SEC Filing  
11/20/2013Asher HolzerDirectorSell1,600$2.69$4,304.00View SEC Filing  
5/31/2013Sol J BarerDirectorBuy20,000$2.26$45,200.00View SEC Filing  
5/30/2013Sol J BarerDirectorBuy20,000$2.07$41,400.00View SEC Filing  
5/29/2013Alan MilinazzoCEOBuy15,000$2.11$31,650.00View SEC Filing  
5/29/2013Sol J BarerDirectorBuy20,000$2.09$41,800.00View SEC Filing  
5/28/2013Sol J BarerDirectorBuy20,000$2.15$43,000.00View SEC Filing  
5/24/2013Sol J BarerDirectorBuy20,000$2.10$42,000.00View SEC Filing  
4/25/2013Sol J BarerDirectorBuy50,000$2.00$100,000.00View SEC Filing  
4/16/2013Alan MilinazzoCEOBuy100,000$2.00$200,000.00View SEC Filing  
4/16/2013Sol J BarerDirectorBuy750,000$2.00$1,500,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

InspireMD (NYSEAMERICAN NSPR) News Headlines

Source:
DateHeadline
InspireMDs CGuard Embolic Prevention System to be Featured at ICCA Stroke 2018 in Warsaw, PolandInspireMDs CGuard Embolic Prevention System to be Featured at ICCA Stroke 2018 in Warsaw, Poland
feeds.benzinga.com - April 19 at 7:34 AM
InspireMD (NSPR) Short Interest Up 66.4% in MarchInspireMD (NSPR) Short Interest Up 66.4% in March
www.americanbankingnews.com - April 10 at 6:35 PM
InspireMD (NSPR) Total Q1 Sales to Exceed $1 MillionInspireMD (NSPR) Total Q1 Sales to Exceed $1 Million
www.streetinsider.com - April 4 at 8:29 AM
InspireMD Anticipates Fifth Consecutive Quarter of Sequential Double Digit Growth; Projects 132% Increase in CGuard EPS Sales for the First Quarter of 2018; Total Quarterly Company Sales to Exceed $1 MillionInspireMD Anticipates Fifth Consecutive Quarter of Sequential Double Digit Growth; Projects 132% Increase in CGuard EPS Sales for the First Quarter of 2018; Total Quarterly Company Sales to Exceed $1 Million
finance.yahoo.com - April 3 at 5:29 PM
InspireMD reports preliminary Q1 salesInspireMD reports preliminary Q1 sales
seekingalpha.com - April 3 at 10:52 AM
InspireMD (NSPR) Receives Regulatory Approval for both CGuard EPS and MGuard Prime in PeruInspireMD (NSPR) Receives Regulatory Approval for both CGuard EPS and MGuard Prime in Peru
www.streetinsider.com - March 29 at 8:35 AM
Blog Exposure - InspireMD Announced Regulatory Approval for CGuard Embolic Prevention System and MGuard Prime in PeruBlog Exposure - InspireMD Announced Regulatory Approval for CGuard Embolic Prevention System and MGuard Prime in Peru
finance.yahoo.com - March 29 at 8:35 AM
Mid-Afternoon Market Update: RH Rises On Upbeat Earnings; InspireMD Shares SlideMid-Afternoon Market Update: RH Rises On Upbeat Earnings; InspireMD Shares Slide
www.nasdaq.com - March 28 at 5:13 PM
Health Care Sector Update for 03/28/2018: SHPG,APRI,NSPRHealth Care Sector Update for 03/28/2018: SHPG,APRI,NSPR
www.nasdaq.com - March 28 at 8:35 AM
Mid-Day Market Update: Dow Rises Over 100 Points; InspireMD Shares Spike HigherMid-Day Market Update: Dow Rises Over 100 Points; InspireMD Shares Spike Higher
www.benzinga.com - March 28 at 8:35 AM
InspireMD, Inc. Announces Pricing of $5.0 Million Public Offering of Common StockInspireMD, Inc. Announces Pricing of $5.0 Million Public Offering of Common Stock
finance.yahoo.com - March 28 at 8:35 AM
InspireMD Receives Regulatory Approval for both CGuard™ EPS and MGuard Prime™ in PeruInspireMD Receives Regulatory Approval for both CGuard™ EPS and MGuard Prime™ in Peru
finance.yahoo.com - March 27 at 8:36 AM
InspireMD (NSPR) Scheduled to Post Earnings on WednesdayInspireMD (NSPR) Scheduled to Post Earnings on Wednesday
www.americanbankingnews.com - March 21 at 1:18 AM
InspireMD Inc (NSPR) Sees Significant Growth in Short InterestInspireMD Inc (NSPR) Sees Significant Growth in Short Interest
www.americanbankingnews.com - March 9 at 6:04 PM
With A -53.98% Earnings Drop, Is InspireMD Inc’s (NYSEMKT:NSPR) Performance A Concern?With A -53.98% Earnings Drop, Is InspireMD Inc’s (NYSEMKT:NSPR) Performance A Concern?
finance.yahoo.com - March 8 at 6:30 PM
InspireMD Announces First Patient Treated with CGuard™ EPS in India InspireMD Announces First Patient Treated with CGuard™ EPS in India 
finance.yahoo.com - March 5 at 8:28 AM
InspireMD Announces Expansion of its Distribution NetworkInspireMD Announces Expansion of its Distribution Network
finance.yahoo.com - March 1 at 8:20 AM
InspireMD Inc (NSPR) Short Interest Down 96.8% in FebruaryInspireMD Inc (NSPR) Short Interest Down 96.8% in February
www.americanbankingnews.com - February 28 at 1:56 AM
InspireMD, Inc. Announces Pricing of Public Offering of Common StockInspireMD, Inc. Announces Pricing of Public Offering of Common Stock
finance.yahoo.com - February 27 at 8:26 AM
InspireMD, Inc. Announces Proposed Public Offering of Common StockInspireMD, Inc. Announces Proposed Public Offering of Common Stock
finance.yahoo.com - February 26 at 5:40 PM
InspireMD Announces Exclusive Distribution, Sales and Marketing Agreement for CGuard EPS in South KoreaInspireMD Announces Exclusive Distribution, Sales and Marketing Agreement for CGuard EPS in South Korea
finance.yahoo.com - February 22 at 5:33 PM
InspireMD Announces Commercial Launch and First Sales of CGuard™ EPS in IndiaInspireMD Announces Commercial Launch and First Sales of CGuard™ EPS in India
finance.yahoo.com - February 20 at 5:41 PM
InspireMD Announces Fourth Quarter and Year-End 2017 Results; CGuard™ EPS Fourth Quarter Sales Increase 211% Versus Same Period Last yearInspireMD Announces Fourth Quarter and Year-End 2017 Results; CGuard™ EPS Fourth Quarter Sales Increase 211% Versus Same Period Last year
finance.yahoo.com - February 14 at 9:49 AM
Today’s Research Reports on Trending Tickers: Eli Lilly and Company and InspireMDToday’s Research Reports on Trending Tickers: Eli Lilly and Company and InspireMD
finance.yahoo.com - February 10 at 9:42 AM
InspireMD Inc (NSPR) Short Interest UpdateInspireMD Inc (NSPR) Short Interest Update
www.americanbankingnews.com - February 9 at 8:28 PM
InspireMD (NSPR) Plans 1-for-35 Reverse Stock SplitInspireMD (NSPR) Plans 1-for-35 Reverse Stock Split
www.streetinsider.com - February 8 at 8:15 AM
InspireMD Announces 1-for-35 Reverse Stock SplitInspireMD Announces 1-for-35 Reverse Stock Split
finance.yahoo.com - February 8 at 8:15 AM
InspireMD, CGuard is Ramping up Revenues, Business Outlook, and Analysts ReviewInspireMD, CGuard is Ramping up Revenues, Business Outlook, and Analysts Review
finance.yahoo.com - February 1 at 9:57 AM
InspireMDs CGuard Embolic Prevention System Featured in a Second Live Case Transmission at LINC 2018 by Leading Interventional CardiologistsInspireMD's CGuard Embolic Prevention System Featured in a Second Live Case Transmission at LINC 2018 by Leading Interventional Cardiologists
finance.yahoo.com - January 31 at 10:17 AM
InspireMD’s CGuard™ Embolic Prevention System Featured in Successful Live Case Transmissions at LINC 2018 by Leading Vascular SurgeonsInspireMD’s CGuard™ Embolic Prevention System Featured in Successful Live Case Transmissions at LINC 2018 by Leading Vascular Surgeons
finance.yahoo.com - January 30 at 10:18 AM
InspireMD’s CGuard Embolic Prevention System to be Prominently Featured in Two Live Case Transmissions at LINC 2018InspireMD’s CGuard Embolic Prevention System to be Prominently Featured in Two Live Case Transmissions at LINC 2018
finance.yahoo.com - January 26 at 3:47 PM
InspireMD Inc (NSPR) Short Interest Up 26.6% in JanuaryInspireMD Inc (NSPR) Short Interest Up 26.6% in January
www.americanbankingnews.com - January 24 at 5:40 PM
InspireMD Announces Publication of an Independent Imaging Study Highlighting the Advantages of CGuard EPS Compared to Another Next Generation Carotid StentInspireMD Announces Publication of an Independent Imaging Study Highlighting the Advantages of CGuard EPS Compared to Another Next Generation Carotid Stent
finance.yahoo.com - January 19 at 11:41 AM
InspireMD Inc (NSPR) Sees Large Growth in Short InterestInspireMD Inc (NSPR) Sees Large Growth in Short Interest
www.americanbankingnews.com - January 10 at 6:06 PM
Today’s Research Reports on Trending Tickers: Akers Biosciences and InspireMD, Inc.Today’s Research Reports on Trending Tickers: Akers Biosciences and InspireMD, Inc.
finance.yahoo.com - January 10 at 10:20 AM
InspireMD (NSPR) Reports Approval of CGuard EPS in India and Agreement with Leading Indian Medical Device DistributorInspireMD (NSPR) Reports Approval of CGuard EPS in India and Agreement with Leading Indian Medical Device Distributor
www.streetinsider.com - January 5 at 4:23 PM
techstockinsider.com: 2 Medical Technology Stocks That Have Investors Attentiontechstockinsider.com: 2 Medical Technology Stocks That Have Investors' Attention
www.finanznachrichten.de - January 5 at 4:23 PM
2 Medical Technology Stocks That Have Investors Attention2 Medical Technology Stocks That Have Investors' Attention
finance.yahoo.com - January 3 at 4:42 PM
InspireMD Schedules Conference Call to Discuss Recent Developments, Preliminary Sales Results and Proposals for Upcoming Shareholder MeetingInspireMD Schedules Conference Call to Discuss Recent Developments, Preliminary Sales Results and Proposals for Upcoming Shareholder Meeting
finance.yahoo.com - January 3 at 4:42 PM
InspireMD Announces Regulatory Approval of CGuard EPS in India; Signs Agreement with Leading Indian Medical Device DistributorInspireMD Announces Regulatory Approval of CGuard EPS in India; Signs Agreement with Leading Indian Medical Device Distributor
finance.yahoo.com - January 3 at 9:32 AM
InspireMD Inc (NSPR) Sees Significant Increase in Short InterestInspireMD Inc (NSPR) Sees Significant Increase in Short Interest
www.americanbankingnews.com - December 27 at 6:38 PM
InspireMD’s CGuard™ Embolic Prevention System Once Again Featured in a Successful Live Clinical Case at Leading Industry ConferenceInspireMD’s CGuard™ Embolic Prevention System Once Again Featured in a Successful Live Clinical Case at Leading Industry Conference
finance.yahoo.com - December 18 at 4:38 PM
InspireMD’s CGuard EPS Demonstrates Improved Outcomes over Carotid Endarterectomy in 50 Patient Comparative Study; Preliminary Results Featured at the 7th Munich Vascular Conference 2017InspireMD’s CGuard EPS Demonstrates Improved Outcomes over Carotid Endarterectomy in 50 Patient Comparative Study; Preliminary Results Featured at the 7th Munich Vascular Conference 2017
finance.yahoo.com - December 7 at 4:56 PM
Five Innovative Biotech Stocks for the New YearFive Innovative Biotech Stocks for the New Year
www.prnewswire.com - December 7 at 10:37 AM
InspireMD Announces Preliminary 2 Year Follow-up Results from the PARADIGM Clinical Study Using CGuard™ EPSInspireMD Announces Preliminary 2 Year Follow-up Results from the PARADIGM Clinical Study Using CGuard™ EPS
finance.yahoo.com - December 5 at 4:37 PM

SEC Filings

InspireMD (NYSEAMERICAN:NSPR) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

InspireMD (NYSEAMERICAN:NSPR) Income Statement, Balance Sheet and Cash Flow Statement

Chart

InspireMD (NYSEAMERICAN NSPR) Stock Chart for Thursday, April, 19, 2018

Loading chart…

This page was last updated on 4/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.